New data showed childhood obesity has hit a record high in recent years, while federal changes such as cuts to food ...

Biocon has received the green light from the Food and Drug Administration, for its complex formulation liraglutide injection, 18 mg/3 ml (6 mg/ml) single-patient-use prefilled pen ...

The FDA inspected the Danish manufacturer in January and February 2025 and found that it did not comply with adverse event reporting regulations. medication approval holders must have documented ...

Broad use of a hormone prescribed for weight loss has spawned a flurry of menu items touted as “GLP-1 friendly,” ...

With close to one million downloads, Shotsy is the most popular GLP-1 tracking app on the market, and now meets patients at ...

Novo Nordisk has been sent a warning letter from the FDA for a series of violations of postmarketing adverse drug experience (PADE) regulations, including failure to report side effects among patients ...

The UK is one of the heaviest nations in Europe now with 64 per cent of the population overweight or obese, and one in four ...

Researchers create the first sex-specific GLP-1 brain atlas, revealing why weight-loss drugs work differently in men and women.

A new study suggests that widely used GLP-1 weight-loss drugs may do more than improve metabolic health: they could also protect the heart after a heart attack. Doctors can often reopen the blocked ...

Wegovy is a Food and Drug Administration-approved weight loss medication for people with obesity or those who are overweight with weight-related health conditions. In recent years, interest in ...

Drug executives say only their GLP-1 drugs are safe for treating obesity and diabetes as they wage a year-long campaign to ...

Here's what happens to your heart, liver, skin, and more.